Fate Therapeutics, Inc.

FATE ·Healthcare, Drug Manufacturers - General, United States

← 5Y 10Y MAX →

Profit History

Revenue Operating Income Net Income

Period	Revenue	Operating Income	Net Income
Mar 2012	$418.0K	—	$-3.2M
Jun 2012	$1.1M	—	$-2.7M
Sep 2012	$528.0K	$-3.7M	$-4.1M
Dec 2012	$643.0K	—	$-4.2M
Mar 2013	$472.0K	$-3.4M	$-3.5M
Jun 2013	$290.0K	$-4.3M	$-5.5M
Sep 2013	$209.0K	$-5.1M	$-6.1M
Dec 2013	$0	$-4.9M	$-5.7M
Mar 2014	—	$-6.9M	$-7.0M
Jun 2014	—	$-6.0M	$-6.1M
Sep 2014	—	$-6.0M	$-6.6M
Dec 2014	—	$-5.9M	$-6.2M
Mar 2015	—	$-7.3M	$-7.9M
Jun 2015	$329.0K	$-7.2M	$-7.8M
Sep 2015	$1.0M	$-6.3M	$-6.9M
Dec 2015	$1.1M	$-6.9M	$-7.4M
Mar 2016	$1.3M	$-7.9M	$-8.4M
Jun 2016	$1.0M	$-8.0M	$-8.4M
Sep 2016	$1.0M	$-8.4M	$-8.7M
Dec 2016	$1.0M	$-7.7M	$-7.9M
Mar 2017	$1.0M	$-10.0M	$-10.1M
Jun 2017	$1.0M	$-9.6M	$-9.6M
Sep 2017	$1.0M	$-10.3M	$-10.7M
Dec 2017	$1.0M	$-12.2M	$-12.5M
Mar 2018	$1.0M	$-14.1M	$-14.1M
Jun 2018	$1.0M	$-19.6M	$-19.7M
Sep 2018	$1.0M	$-16.7M	$-16.8M
Dec 2018	$1.7M	$-16.7M	$-16.0M
Mar 2019	$2.6M	$-20.4M	$-19.8M
Jun 2019	$2.8M	$-24.1M	$-23.5M
Sep 2019	$2.4M	$-27.1M	$-26.6M
Dec 2019	$2.8M	$-29.1M	$-28.3M
Mar 2020	$2.5M	$-34.5M	$-33.5M
Jun 2020	$5.5M	$-28.7M	$-28.1M
Sep 2020	$7.6M	$-31.5M	$-58.7M
Dec 2020	$15.9M	$-33.4M	$-53.1M
Mar 2021	$11.1M	$-46.2M	$-45.1M
Jun 2021	$13.4M	$-46.8M	$-55.1M
Sep 2021	$14.2M	$-54.6M	$-43.3M
Dec 2021	$17.1M	$-69.4M	$-68.6M
Mar 2022	$18.4M	$-74.5M	$-65.7M
Jun 2022	$18.5M	$-83.1M	$-76.1M
Sep 2022	$15.0M	$-86.4M	$-83.6M
Dec 2022	$44.4M	$-64.4M	$-56.4M
Mar 2023	$59.0M	$-28.6M	$-18.9M
Jun 2023	$933.0K	$-62.6M	$-52.8M
Sep 2023	$1.9M	$-51.3M	$-45.2M
Dec 2023	$1.7M	$-48.1M	$-44.1M
Mar 2024	$1.9M	$-51.1M	$-48.0M
Jun 2024	$6.8M	$-45.1M	$-38.4M
Sep 2024	$3.1M	$-52.4M	$-47.7M
Dec 2024	$1.9M	$-61.7M	$-52.2M
Mar 2025	$1.6M	$-41.3M	$-37.6M
Jun 2025	$1.9M	$-37.0M	$-34.1M
Sep 2025	$1.7M	$-34.7M	$-32.3M
Dec 2025	$1.4M	$-34.7M	$-32.4M
Mar 2026	$1.3M	$-33.0M	$-31.2M
Jun 2026	$2.1M	$-31.1M	$-30.2M